Percio S. S. Gulko

Prof. Percio S. S. Gulko


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
RARizi Ai
Rizi Ai
TLTeresina Laragione
Teresina Laragione
DHDeepa Hammaker
Deepa Hammaker
DBDavid L. Boyle
David L. Boyle
AWAndre Wildberg
Andre Wildberg
GFGary S. Firestein
Gary S. Firestein
Epigenetics contributes to the pathogenesis of immune-mediated diseases like rheumatoid arthritis (RA). Here we show the first comprehensive epigenomic characterization of RA fibroblast-like synoviocytes (FLS), including histone modifications (H3K27ac, H3K4me1, H3K4me3, H3K36me3, H3K27me3, and H3K9me3), open chromatin, RNA expression and whole-genome DNA methylation. To address complex multidimensional relationship and reveal epigenetic regulation of RA, we perform integrative analyses using a novel unbiased method to identify genomic regions with similar profiles. Epigenomically similar regions exist in RA cells and are associated with active enhancers and promoters and specific transcription factor binding motifs. Differentially marked genes are enriched for immunological and unexpected pathways, with “Huntington’s Disease Signaling” identified as particularly prominent. We validate the relevance of this pathway to RA by showing that Huntingtin-interacting protein-1 regulates FLS invasion into matrix. This work establishes a high-resolution epigenomic landscape of RA and demonstrates the potential for integrative analyses to identify unanticipated therapeutic targets.

17 May 2023 in EBioMedicine
Verified
Journal Article
Open access
TLTeresina Laragione
Teresina Laragione
CHCarolyn Harris
Carolyn Harris
NANasim Azizgolshani
Nasim Azizgolshani
CBChristine Beeton
Christine Beeton
GBGerold Bongers
Gerold Bongers
PGPercio S. S. Gulko
Percio S. S. Gulko
Rheumatoid arthritis (RA) is a common autoimmune disease with emerging environmental and microbiome risk factors. The western diet is typically deficient in magnesium (Mg), and there is some evidence suggesting that Mg may have anti-inflammatory properties. But the actual role of Mg supplementation in arthritis or in T cell subsets has not been explored. We investigated the role of a high Mg diet in two different mouse models of RA induced with the KRN serum, and collagen-induced arthritis. We also characterized the phenotypes of splenocytes, gene expression, and an extensive intestinal microbiome analyses including fecal material transplantation (FMT). The high Mg diet group was significantly protected with reduced arthritis severity and joint damage, and reduced expression of IL-1β, IL-6, and TNFα. The high Mg group also had increased numbers of Foxp3+ Treg cells and IL-10-producing T cells. The high Mg protective effect disappeared in IL-10 knockout mice. FMT from the high Mg diet mice recreated the phenotypes seen in the diet-treated mice, with reduced arthritis severity, increased Foxp3+ Treg, and increased IL-10-producing T cells. Intestinal microbiome analyses using 16S rDNA sequencing revealed diet-specific changes, including reduced levels of RA-associated Prevotella in the high Mg group, while increasing levels of Bacteroides and other bacteria associated with increased production of short-chain fatty acids. Metagenomic analyses implicated additional pathways including L-tryptophan biosynthesis and arginine deiminase. We describe a new role for Mg in suppressing arthritis, in expanding Foxp3+ T reg cells and in the production of IL-10, and show that these effects are mediated by the intestinal microbiome. Our discoveries suggest a novel strategy for modifying the intestinal microbiome to treat RA and other autoimmune and inflammatory diseases. None.

1 June 2015 in Clinical Immunology
Verified
Journal Article
Closed access
TLTeresina Laragione
Teresina Laragione
KCKai F. Cheng
Kai F. Cheng
MTMark R. Tanner
Mark R. Tanner
MHMingzhu He
Mingzhu He
CBChristine Beeton
Christine Beeton
PGPercio S. S. Gulko
Percio S. S. Gulko

1 May 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
TLTeresina Laragione
Teresina Laragione
CHCarolyn Harris
Carolyn Harris
PGPercio S. S. Gulko
Percio S. S. Gulko

1 March 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MFMirian Farinon
Mirian Farinon
VCVanessa S. Clarimundo
Vanessa S. Clarimundo
GPGraziele P.R. Pedrazza
Graziele P.R. Pedrazza
PGPercio S. S. Gulko
Percio S. S. Gulko
JZJosé Angelo Silveira Zuanazzi
José Angelo Silveira Zuanazzi
POPatricia G. de Oliveira
Patricia G. de Oliveira

7 January 2019 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
MTMark R. Tanner
Mark R. Tanner
MPMichael Pennington
Michael Pennington
SCSatendra S. Chauhan
Satendra S. Chauhan
TLTeresina Laragione
Teresina Laragione
PGPercio S. S. Gulko
Percio S. S. Gulko
CBChristine Beeton
Christine Beeton
Fibroblast-like synoviocytes (FLS) and CCR7− effector memory T (TEM) cells are two of the major cell types implicated in the progression of rheumatoid arthritis (RA). In particular, FLS become highly invasive, whereas TEM cells proliferate and secrete proinflammatory cytokines, during RA. FLS and T cells may also interact and influence each other’s phenotypes. Inhibition of the pathogenic phenotypes of both FLS and TEM cells can be accomplished by selectively blocking the predominant potassium channels that they upregulate during RA: KCa1.1 (BK, Slo1, MaxiK, KCNMA1) upregulated by FLS and Kv1.3 (KCNA3) upregulated by activated TEM cells. In this study, we investigated the roles of KCa1.1 and Kv1.3 in regulating the interactions between FLS and TEM cells and determined if combination therapies of KCa1.1- and Kv1.3-selective blockers are more efficacious than monotherapies in ameliorating disease in rat models of RA. We used in vitro functional assays to assess the effects of selective KCa1.1 and Kv1.3 channel inhibitors on the interactions of FLS isolated from rats with collagen-induced arthritis (CIA) with syngeneic TEM cells. We also used flow cytometric analyses to determine the effects of KCa1.1 blockers on the expression of proteins used for antigen presentation on CIA-FLS. Finally, we used the CIA and pristane-induced arthritis models to determine the efficacy of combinatorial therapies of KCa1.1 and Kv1.3 blockers in reducing disease severity compared with monotherapies. We show that the interactions of FLS from rats with CIA and of rat TEM cells are regulated by KCa1.1 and Kv1.3. Inhibiting KCa1.1 on FLS reduces the ability of FLS to stimulate TEM cell proliferation and migration, and inhibiting Kv1.3 on TEM cells reduces TEM cells’ ability to enhance FLS expression of KCa1.1 and major histocompatibility complex class II protein, as well as stimulates their invasion. Furthermore, we show that combination therapies of selective KCa1.1 and Kv1.3 blockers are more efficacious than monotherapies at reducing signs of disease in two rat models of RA. Our results demonstrate the importance of KCa1.1 and Kv1.3 in regulating FLS and TEM cells during RA, as well as the value of combined therapies targeting both of these cell types to treat RA.